https://www.selleckchem.com/pr....oducts/eflornithine-
In addition, Wog treatment prevented oxidative stress and improved cardiac hypertrophy in mice that underwent TAC. Using gene-specific siRNA for , we discovered that these antioxidative effects of Wog are mediated through Nrf-2 induction. Our results provide further evidence for the potential use of Wog as an antioxidative agent for treatment of cardiac hypertrophy, and Nrf-2 might serve as a therapeutic target in the treatment of cardiac hypertrophy. Our results provide further evidence for the potential use
Like
Comment
Share
